Overview

Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor

Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
Our study aims to compare the efficacy and safety of Chemotherapy Alone Versus D2 distal gastrectomy and metastasectomy plus Chemotherapy for gastric cancer (GC) with one non-curable Factor
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Capecitabine
Oxaliplatin